Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiovascular surgery devices include devices used in cardiovascular surgeries such as coronary artery bypass surgery. Perfusion disposables consist of the disposable items used during cardiopulmonary bypass surgery. GlobalData uses proprietary data and analytics to provide a comprehensive report on the perfusion disposables devices market, including market shares of different players within the US. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the perfusion disposables market in the US was Abbott Laboratories followed by LivaNova, Getinge, Abiomed, Terumo, Medtronic, Braile Biomedica, Edwards Lifesciences, Eurosets, Fresenius SE & Co, Nipro and MicroPort Scientific.

Perfusion disposables devices include custom packs and oxygenators. One oxygenator and one custom tubing pack is used for each on-pump procedure. Perfusion Oxygenators are disposable gas exchange devices in extracorporeal circuits which replace the role of the lungs by removing CO2 and oxygenating venous blood prior to being returned to the heart or arterial system. Perfusion Kits contain an oxygenator and pump and may also include cannulae and additional tubing sets for use in extracorporeal circuits. Custom Tubing packs are made from non-toxic medical grade PVC tubing and are used exclusively in combination with heart lung machine and other devices of the system, such as oxygenator, blood cardioplegia delivery system.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the perfusion disposables devices market within the US was expected to be over $2000m in 2022.

For the latest complete market share analysis of perfusion disposables device market in the US, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.